139 related articles for article (PubMed ID: 165252)
1. Mechanism of avian estrogen-induced hypertriglyceridemia: evidence for overproduction of triglyceride.
Kudzma DJ; St Claire F; DeLallo L; Friedberg SJ
J Lipid Res; 1975 Mar; 16(2):123-33. PubMed ID: 165252
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogen on very-low-density lipoprotein triacylglycerol metabolism in chicks.
Park JR; Cho BH
Biochim Biophys Acta; 1990 Jul; 1045(2):180-6. PubMed ID: 2378910
[TBL] [Abstract][Full Text] [Related]
3. Contribution of very low-density lipoprotein triglyceride fatty acids to postabsorptive free fatty acid flux in obese humans.
Bush NC; Triay JM; Gathaiya NW; Hames KC; Jensen MD
Metabolism; 2014 Jan; 63(1):137-40. PubMed ID: 24140092
[TBL] [Abstract][Full Text] [Related]
4. Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets.
Quarfordt SH; Frank A; Shames DM; Berman M; Steinberg D
J Clin Invest; 1970 Dec; 49(12):2281-97. PubMed ID: 5480854
[TBL] [Abstract][Full Text] [Related]
5. Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.
Wang W; Basinger A; Neese RA; Shane B; Myong SA; Christiansen M; Hellerstein MK
Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E540-7. PubMed ID: 11171611
[TBL] [Abstract][Full Text] [Related]
6. Utilization of exogenous free fatty acids for the production of very low density lipoprotein triglyceride by livers of carbohydrate-fed rats.
Schonfeld G; Pfleger B
J Lipid Res; 1971 Sep; 12(5):614-21. PubMed ID: 5098397
[TBL] [Abstract][Full Text] [Related]
7. The transport of triglyceride in the high-density lipoproteins of human plasma.
Barter PJ; Connor WE
J Lab Clin Med; 1975 Feb; 85(2):260-72. PubMed ID: 163284
[TBL] [Abstract][Full Text] [Related]
8. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
9. Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands. Evidence for genetic control of triglyceride removal.
Sane T; Nikkilä EA
Arteriosclerosis; 1988; 8(3):217-26. PubMed ID: 3370019
[TBL] [Abstract][Full Text] [Related]
10. The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia.
Dunn FL; Raskin P; Bilheimer DW; Grundy SM
Metabolism; 1984 Feb; 33(2):117-23. PubMed ID: 6582347
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of very low density lipoproteins in the cockerel. Effects of estrogen.
Chan L; Jackson RL; O'Malley BW; Means AR
J Clin Invest; 1976 Aug; 58(2):368-79. PubMed ID: 182719
[TBL] [Abstract][Full Text] [Related]
12. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
[TBL] [Abstract][Full Text] [Related]
13. Suppression by diets rich in fish oil of very low density lipoprotein production in man.
Nestel PJ; Connor WE; Reardon MF; Connor S; Wong S; Boston R
J Clin Invest; 1984 Jul; 74(1):82-9. PubMed ID: 6736254
[TBL] [Abstract][Full Text] [Related]
14. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G
Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657
[TBL] [Abstract][Full Text] [Related]
15. Very-low-density lipoprotein triglyceride metabolism in non-insulin-dependent diabetes mellitus. Relationship to plasma insulin and free fatty acids.
Howard BV; Reitman JS; Vasquez B; Zech L
Diabetes; 1983 Mar; 32(3):271-6. PubMed ID: 6337905
[TBL] [Abstract][Full Text] [Related]
16. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
[TBL] [Abstract][Full Text] [Related]
17. Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia.
Dunn FL; Grundy SM; Bilheimer DW; Havel RJ; Raskin P
Metabolism; 1985 Apr; 34(4):316-24. PubMed ID: 3884962
[TBL] [Abstract][Full Text] [Related]
18. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus.
Howard BV; Abbott WG; Egusa G; Taskinen MR
Am Heart J; 1987 Feb; 113(2 Pt 2):522-6. PubMed ID: 3544765
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
[TBL] [Abstract][Full Text] [Related]
20. Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer.
Gormsen LC; Jensen MD; Nielsen S
J Lipid Res; 2006 Jan; 47(1):99-106. PubMed ID: 16234572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
